Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGolden Pros Regulatory News (GPM)

Share Price Information for Golden Pros (GPM)

Share Price is delayed by 15 minutes
Get Live Data
103.00    -7.00 (-6.36%)
Bid:
101.00
Ask:
105.00
Spread: 4.00 (3.96%)
Market Cap: £101.61m
GPM Live PriceLast checked at - London Stock Exchange

Intraday Golden Pros Share Chart

Board Changes and Director Declaration

26 Mar 2026 07:00

RNS Number : 1498Y
Golden Prospect Precious Metals Ltd
26 March 2026
 

26 March 2026

Golden Prospect Precious Metals Limited (the "Company" or "GPM")

 

Board Changes and Director Declaration

 

The Board of the Company is pleased to announce that Christopher Waldron has been appointed as a Non-Executive Director and member of GPM's Audit, Management Engagement, and Remuneration & Nomination Committees with effect from 26 March 2026.

Mr Waldron, aged 61, is a resident of Guernsey. He is Chair of Crystal Amber Fund Limited and a director of Bluefield Solar Income Fund as well as a number of unlisted companies. He has over 35 years' experience as an investment manager and until 2013 was Chief Executive of the Edmond de Rothschild Group in the Channel Islands. Mr Waldron previously held investment management positions with James Capel, Bank of Bermuda, the Jardine Matheson Group and Fortis. A graduate of the University of London and Cranfield University, he is a Fellow of the Chartered Institute of Securities and Investment.

The Board of Directors considers Mr Waldron to be independent on appointment per the AIC Corporate Governance Code.

Toby Birch, Chairman, commented:

"I am pleased to welcome Chris as an Independent Non-Executive Director of the Company. His extensive investment management experience and leadership roles within listed and unlisted companies will bring significant insight and depth to GPM's governance and strategic oversight."

Directors' Declarations Pursuant to Rule 6.4.8R of the UK Listing Rules

 

Mr Waldron is currently a director of the below public companies:

 

· Bluefield Solar Income Fund Ltd; and

· Crystal Amber Fund Limited.

 

Within the last five years, Mr Waldron has been but is no longer a director of the below public company:

· UK Mortgages Limited.

 

There are no further disclosures required under Rule 6.4.8R of the UK Listing Rules in respect of Mr Waldron.

 

 

Enquiries

 

Apex Fund and Corporate Services (Guernsey) Limited

James Taylor

 

+44 (0) 203 5303 600

GPPMCoSec@apexgroup.com

 

About Golden Prospect Precious Metals 

Golden Prospect Precious Metals Limited is a closed-ended investment company incorporated with limited liability in Guernsey on 16 October 2006. The Company's investment objective is to provide Shareholders with capital growth from a portfolio of companies involved in the precious metals sector. For the latest factsheet and other information, click here.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPPUUPWUPQGMA
Date   Source Headline
13th Jan 202612:02 pmRNSNet Asset Value(s)
12th Jan 202612:27 pmRNSNet Asset Value(s)
9th Jan 202611:26 amRNSNet Asset Value(s)
8th Jan 202611:26 amRNSNet Asset Value(s)
7th Jan 20262:15 pmRNSNet Asset Value(s)
6th Jan 20261:36 pmRNSNet Asset Value(s)
5th Jan 202612:52 pmRNSNet Asset Value(s)
2nd Jan 20262:09 pmRNSNet Asset Value(s)
31st Dec 202512:44 pmRNSNet Asset Value(s)
30th Dec 202512:48 pmRNSNet Asset Value(s)
29th Dec 202510:47 amRNSNet Asset Value(s)
24th Dec 202511:05 amRNSNet Asset Value(s)
23rd Dec 202511:34 amRNSNet Asset Value(s)
23rd Dec 20259:37 amRNSMonthly Investor Report November 2025
23rd Dec 20259:37 amRNSMonthly Investor Report November 2025
23rd Dec 20257:00 amRNSFurther re Result of Subscription Rights Exercise
23rd Dec 20257:00 amRNSFurther re Result of Subscription Rights Exercise
22nd Dec 20255:22 pmRNSNet Asset Value(s)
19th Dec 20252:59 pmRNSNet Asset Value(s)
18th Dec 202511:04 amRNSNet Asset Value(s)
17th Dec 20251:38 pmRNSNet Asset Value(s)
16th Dec 20251:34 pmRNSNet Asset Value(s)
15th Dec 20252:23 pmRNSNet Asset Value(s)
12th Dec 202512:40 pmRNSNet Asset Value(s)
11th Dec 20253:13 pmRNSNet Asset Value(s)
10th Dec 20251:36 pmRNSNet Asset Value(s)
9th Dec 20251:21 pmRNSNet Asset Value(s)
8th Dec 202511:46 amRNSNet Asset Value(s)
5th Dec 20251:31 pmRNSNet Asset Value(s)
4th Dec 20253:04 pmRNSNet Asset Value(s)
4th Dec 20257:00 amRNSReplacement - Net Asset Value(s)
3rd Dec 20254:37 pmRNSNet Asset Value(s)
3rd Dec 20258:00 amRNSShareholders Notification 2026 Subscription Rights
3rd Dec 20257:00 amRNSFurther re Result of subscription rights exercise
2nd Dec 20251:47 pmRNSNet Asset Value(s)
2nd Dec 202510:58 amRNSResult of subscription rights exercise
1st Dec 20252:06 pmRNSNet Asset Value(s)
28th Nov 202512:42 pmRNSNet Asset Value(s)
27th Nov 202512:55 pmRNSNet Asset Value(s)
27th Nov 20257:00 amRNS-RKepler Trust Intelligence: New Research
26th Nov 202512:19 pmRNSNet Asset Value(s)
26th Nov 202511:12 amRNSMonthly Investor Report - October 2025
25th Nov 202511:35 amRNSNet Asset Value(s)
24th Nov 202512:32 pmRNSNet Asset Value(s)
21st Nov 20253:14 pmRNSNet Asset Value(s)
21st Nov 20257:00 amRNS-RInvestment Company of the Year Awards 2025
20th Nov 202511:47 amRNSNet Asset Value(s)
19th Nov 202511:43 amRNSNet Asset Value(s)
18th Nov 202512:32 pmRNSNet Asset Value(s)
17th Nov 20254:18 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.